Walter Reed Army Institute of Research’s mission is to discover, design and develop solutions for military relevant infectious disease and brain health threats through innovative research protecting and optimizing warfighter lethality.

Studies by the Military Infectious Disease Research Program’s Infectious Disease Threat Prioritization Panel has found that Diarrhoea remains the No. 1 infectious disease threat among 57 others based on its impact to soldier readiness. Bacterial pathogens remains the predominant risk and is though to account for the majority of cases of Traveller’s Diarrhoea.

Immuron has partnered with the Walter Reed Army Institute of Research, Armed Forces Research Institute of Medical Services and Naval Medical Research Centre to test Travelan against Shigella, ETEC, Vibrio cholerae and Campylobacter jejuni isolates. In a recent preclinical study, Travelan has prevented the development of Shigellosis in 75% of those receiving therapy.

Read more about Travelan’s impact on countermeasures towards diarrheal diseases here.